Affordable Access

Access to the full text

Management of cystic pancreatic lesions

Authors
  • Sahora, Klaus1
  • Schindl, Martin1
  • 1 Medizinische Universität Wien, Universitätsklinik für Chirurgie, Comprehensive Cancer Center Vienna, Währinger Gürtel 18–20, Vienna, 1090, Austria , Vienna (Austria)
Type
Published Article
Journal
European Surgery
Publisher
Springer Vienna
Publication Date
May 08, 2019
Volume
51
Issue
3
Pages
121–125
Identifiers
DOI: 10.1007/s10353-019-0581-1
Source
Springer Nature
Keywords
License
Green

Abstract

BackgroundThree decades ago, cystic neoplasia of the pancreas were a relatively unknown and poorly classified tumor entity. Nowadays, they account for a large proportion of treated lesions in the field of pancreatic surgery. Depending on the cyst type and morphology, a conservative and observational treatment approach has become standard in selected cases. Cystic tumors of the pancreas include both, neoplastic cysts with a variable malignant potential and pseudocysts, which occur as a consequence of a previous pancreatis.MethodsContrast-enhanced multiphase computed tomographic (CT) scan, magnetic resonance imaging (MRI) with the possibility of non-invasive cholangiopancreatography (MRCP) and endoscopic ultrasound (EUS) are the key methods for detailed diagnostic evaluation and risk assessment of cystic pancreatic tumors.ResultsTreatment of cystic tumors of the pancreas is safe according the published guidelines.ConclusionIn patients with a confirmed diagnosis of the cyst subtype, pancreatic resection should be performed in surgically fit patients for intraductal papillary mucinous neoplasia (IPMN) with main duct and mixed type appearance, mucinous cystic neoplasia (MCN) and solid pseudopapillary neoplasia (SPN) regardless their size.

Report this publication

Statistics

Seen <100 times